Omega Healthcare Investors OHI Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Omega Healthcare Investors in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Omega Healthcare Investors’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Omega Healthcare Investors's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Omega Healthcare Investors's accounts receivable, credit loss expense (reversal)?
- Omega Healthcare Investors (OHI) reported accounts receivable, credit loss expense (reversal) of -$3.29M in Q1 2026.
- How has Omega Healthcare Investors's accounts receivable, credit loss expense (reversal) changed year-over-year?
- Omega Healthcare Investors's accounts receivable, credit loss expense (reversal) decreased by 164.7% year-over-year, from $5.09M to -$3.29M.
- What is the long-term trend for Omega Healthcare Investors's accounts receivable, credit loss expense (reversal)?
- Over 4 years (2021 to 2025), Omega Healthcare Investors's accounts receivable, credit loss expense (reversal) has grown at a -58.4% compound annual growth rate (CAGR), from $77.73M to $2.34M.